flatexDEGIRO (XTRA:FTK) has put fresh numbers on the table for Q2 2026, with revenue of €144.6 million and net income of €61.3 million, as the market weighs these figures against the stock’s current price of €36.72. The company has seen revenue move from €114.1 million in Q2 2025 to €144.6 million in Q2 2026, while quarterly net income shifted from €39.5 million to €61.3 million over the same period. This gives investors a clear view of how the top and bottom lines are tracking into the latest quarter. With trailing 12 month net profit margin now described at 31.6% versus 26.1% a year earlier, these results put profitability quality and margin resilience firmly in focus for anyone following the story.
See our full analysis for flatexDEGIRO.With the headline figures set, the next step is to see how these earnings stack up against the widely held narratives around flatexDEGIRO, from growth potential to perceived risks, and where the latest margins either support or push back on those views.
See what the community is saying about flatexDEGIRO
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for flatexDEGIRO on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Given the mix of optimism and caution around flatexDEGIRO, it makes sense to review the details yourself, compare the potential rewards, and decide how comfortable you are with the current setup. To see which positives stand out most clearly in the data, start with the 4 key rewards.
For all the strengths in flatexDEGIRO's latest results, some investors may still feel uneasy about paying a P/E above the wider German Capital Markets industry when part of the current margin and earnings profile is linked to trading activity and interest income that analysts do not treat as permanent.
If you want more comfort that valuation and fundamentals line up without leaning on potentially temporary earnings drivers, it is worth checking companies in the 236 high quality undervalued stocks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com